In SIRPα−/− mice, immune activation due to the same irradiation dose (8 Gy) is higher for KPC tumor than Pan02 and MC38 tumors, suggesting that KPC cells can be more susceptible to SIRPα-based treatment under RT (Table 2). This evidence concerns the gene SIRPA and neoplasm.